Wealthedge Investment Advisors LLC Takes $1.29 Million Position in Humana Inc. $HUM

Wealthedge Investment Advisors LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,272 shares of the insurance provider’s stock, valued at approximately $1,289,000.

Several other institutional investors have also modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Humana by 16.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock valued at $300,728,000 after acquiring an additional 158,528 shares in the last quarter. Focus Partners Wealth increased its position in shares of Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after purchasing an additional 3,281 shares in the last quarter. Swedbank AB raised its stake in Humana by 5.3% in the 2nd quarter. Swedbank AB now owns 100,397 shares of the insurance provider’s stock valued at $24,545,000 after purchasing an additional 5,032 shares during the last quarter. Circle Wealth Management LLC purchased a new position in Humana in the 1st quarter valued at $425,000. Finally, Kera Capital Partners Inc. purchased a new position in Humana in the 2nd quarter valued at $253,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Barclays cut their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a report on Tuesday, November 25th. Wells Fargo & Company increased their price target on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Guggenheim restated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Truist Financial dropped their target price on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $295.94.

Humana Price Performance

HUM opened at $245.77 on Monday. The stock’s 50-day moving average price is $263.19 and its 200 day moving average price is $257.04. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The firm has a market cap of $29.56 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 1.71 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same period in the prior year, the firm earned $4.16 earnings per share. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. As a group, sell-side analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s dividend payout ratio is currently 33.18%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.